$SYRS

Syros Pharmaceuticals Inc.

  • NASDAQ
  • Health Technology
  • Biotechnology
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

PRICE

$6.09 ▲1.498%

Last Close

VOLUME

222,457

DAY RANGE

5.994 - 6.225

52 WEEK

2.09 - 8.17

Join Discuss about SYRS with like-minded investors

profile
@dros #droscrew
recently

Positive Initiations 11/10: $A $ABBV $ALGS $ASAN $BLFS $BLI $BMRA $BRKS $CDMO $CSTL $CYRX $DHR $EAR $HBIO $OCX $PLAN $PRAX $RGEN $SYRS $TARS $VRM $WK $WST $XGN

119 Replies 9 👍 15 🔥

profile
@dros #droscrew
recently

Upgrades 11/4: $ADTN $AM $AMD $AMZN $BIDU $FMS $SPR $SYRS $SYY $TER $VC

94 Replies 9 👍 10 🔥

Key Metrics

Market Cap

37.87 M

Beta

0.30

Avg. Volume

207.09 K

Shares Outstanding

6.30 M

Yield

0%

Public Float

0

Next Earnings Date

Next Dividend Date

Company Information

syros pharmaceuticals is a life sciences company that is focused on treating disease by mapping gene regulatory circuits and modulating the factors that regulate gene expression. syros has pioneered world-leading gene control research and drug discovery capabilities with a proven ability to integrate disease biology and genomic data--a proficiency that is not well represented in pharmaceutical r&d. central to the syros approach is a proprietary platform of carefully integrated assay technologies, bioinformatics, and biologic insights developed by members of syros' senior leadership. while this scientific approach has applications in many therapeutic areas, syros has demonstrated success initially in oncology, where it may help address numerous unmet medical needs.

CEO: Nancy Simonian

Website:

HQ: 35 Cambridge Park Drive Cambridge, 02140 Massachusetts

Related News